1. Phase II study of 5-day continuous infusion ofcis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer

   • Yoshikuni Saito
   • Kiyoshi Mori
   • Naoto Miyazawa

   OriginalPaper Pages: 389 - 392

2. Phase II study of (glycolate-O,O′) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer

   • Masaaki Fukuda
   • Tetsu Shinkai
   • Nagahiro Saijo

   OriginalPaper Pages: 393 - 396

3. Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells

   • Richard H. Peters
   • Kevin Ballard
   • Robert K. Stuart

   OriginalPaper Pages: 397 - 402

4. Cardiac toxicity and antitumor activity of 4′-deoxy-4′-iodo-doxorubicinol

   • Romano Danesi
   • Antonio Marchetti
   • Mario Del Tacca

   OriginalPaper Pages: 403 - 408

5. Pharmacokinetics of the recombinant fusion protein DAB₄₈₆IL-2 in animal models

   • Patricia Bacha
   • Serene Forte
   • Michael Rosenblum

   OriginalPaper Pages: 409 - 414

6. Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig hearts

   • Gerhard Stark
   • Ulrike Stark
   • Helmut A. Tritthart

   OriginalPaper Pages: 415 - 418

7. Clinical pharmacokinetics of intravenously injected tritiated vinzolidine

   • Willi Kreis
   • Daniel R. Budman
   • Robert L. Nelson

   OriginalPaper Pages: 419 - 422

8. Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity ofcis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline

   • Joseph P. Eder
   • Beverly A. Teicher
   • Lowell E. Schnipper

   OriginalPaper Pages: 423 - 428

9. Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity

   • Lincoln L. H. Tsang
   • Peter B. Farmer
   • John A. Slack

   OriginalPaper Pages: 429 - 436

10. Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro

    • Andreas W. Himmelmann
    • Susanne Danhauser-Riedl
    • Wolfgang E. Berdel

    OriginalPaper Pages: 437 - 443

11. The influence of partial hepatectomy on the pharmacokinetics of preoperatively injected 4′-epidoxorubicin in rats

    • Kirsten Sundby Hall
    • Liv Endresen
    • Hans Erik Rugstad

    OriginalPaper Pages: 444 - 448

12. Weekly fluorouracil and high-dose leucovorin: efficacy and treatment of cutaneous toxicity

    • Joanne E. Mortimer
    • Ian Anderson

    OriginalPaper Pages: 449 - 452

13. Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas

    • Salvatore Toma
    • Tiziana Coialbu
    • Riccardo Rosso

    OriginalPaper Pages: 453 - 456

14. Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia

    • Lawrence Panasci
    • George Shenouda
    • Richard Margolese

    OriginalPaper Pages: 457 - 460

15. Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice

    • Kan-ei Lee
    • Masatsugu Iwamura
    • Abraham T. K. Cockett

    Short Communication Pages: 461 - 463

16. Phase II trial of carboplatin and vinblastine in advanced squamous-cell carcinoma of the head and neck

    • S. EL Sayed
    • R. P. Symonds
    • J. McGarva

    Short Communication Pages: 464 - 466

17. Renal effects of S10036 in man

    • G. Deray
    • D. Khayat
    • C. Jacobs

    Short Communication Pages: 467 - 468